CRISPR and Cas Genes Market

CRISPR and Cas Genes Market Study by Vector-based Cas and DNA-free Cas for Genome Engineering, Disease Models, and Functional Genomes from 2023 to 2033

Analysis of CRISPR and Cas Genes Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Request FREE Sample

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

        4.2.1. Global Market Size (US$ Mn) Forecast, 2023–2033

        4.2.2. Global Market Outlook

        4.2.3. Evolution of CRISPRs

        4.2.4. Research institutes involved in CRISPR Research

        4.2.5. CRISPR: Funding & Investment

        4.2.6. Mergers and Acquisitions

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. Global Market Analysis and Forecasts, by Product

    5.1. Introduction & Definition

    5.2. Market Value Forecast, by Product, 2023–2033

        5.2.1. Vector-based Cas

        5.2.2. DNA-free Cas

    5.3. Market Attractiveness, by Product

6. Global Market Analysis and Forecasts, by Application

    6.1. Introduction & Definition

    6.2. Market Value Forecast, by Application, 2023–2033

        6.2.1. Genome Engineering

        6.2.2. Disease Models

        6.2.3. Functional Genomics

        6.2.4. Knockdown/activation

        6.2.5. Others

    6.3. Market Attractiveness, by Application

7. Global Market Analysis and Forecasts, by End user

    7.1. Introduction & Definition

    7.2. Market Value Forecast, by End-user, 2023–2033

        7.2.1. Biotechnology & Pharmaceutical Companies

        7.2.2. Academic & Government Research Institutes

        7.2.3. Contract Research Organizations

    7.3. Market Attractiveness, by End-user

8. Global Market Analysis and Forecasts, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness, by Country/Region

9. North America Market Analysis and Forecast

    9.1. Introduction

    9.2. Market Value Forecast, by Product, 2023–2033

        9.2.1. Vector-based Cas

        9.2.2. DNA-free Cas

    9.3. Market Value Forecast, by Application, 2023–2033

        9.3.1. Genome Engineering

        9.3.2. Disease Models

        9.3.3. Functional Genomics

        9.3.4. Knockdown/activation

        9.3.5. Others

    9.4. Market Value Forecast, by End-user, 2023–2033

        9.4.1. Biotechnology & Pharmaceutical Companies

        9.4.2. Academic & Government Research Institutes

        9.4.3. Contract Research Organizations

    9.5. Market Value Forecast, by Country, 2023–2033

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Product

        9.6.2. By Application

        9.6.3. By End-user

        9.6.4. By Country

10. Europe Market Analysis and Forecast

    10.1. Introduction

    10.2. Market Value Forecast, by Product, 2023–2033

        10.2.1. Vector-based Cas

        10.2.2. DNA-free Cas

    10.3. Market Value Forecast, by Application, 2023–2033

        10.3.1. Genome Engineering

        10.3.2. Disease Models

        10.3.3. Functional Genomics

        10.3.4. Knockdown/activation

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2023–2033

        10.4.1. Biotechnology & Pharmaceutical Companies

        10.4.2. Academic & Government Research Institutes

        10.4.3. Contract Research Organizations

    10.5. Market Value Forecast, by Country/Sub-region, 2023–2033

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country/Sub-region

11. Asia Pacific Market Analysis and Forecast

    11.1. Introduction

    11.2. Market Value Forecast, by Product, 2023–2033

        11.2.1. Vector-based Cas

        11.2.2. DNA-free Cas

    11.3. Market Value Forecast, by Application, 2023–2033

        11.3.1. Genome Engineering

        11.3.2. Disease Models

        11.3.3. Functional Genomics

        11.3.4. Knockdown/activation

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2023–2033

        11.4.1. Biotechnology & Pharmaceutical Companies

        11.4.2. Academic & Government Research Institutes

        11.4.3. Contract Research Organizations

    11.5. Market Value Forecast, by Country/Sub-region, 2023–2033

        11.5.1. Japan

        11.5.2. China

        11.5.3. India

        11.5.4. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Latin America Market Analysis and Forecast

    12.1. Introduction

    12.2. Market Value Forecast, by Product, 2023–2033

        12.2.1. Vector-based Cas

        12.2.2. DNA-free Cas

    12.3. Market Value Forecast, by Application, 2023–2033

        12.3.1. Genome Engineering

        12.3.2. Disease Models

        12.3.3. Functional Genomics

        12.3.4. Knockdown/activation

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2023–2033

        12.4.1. Biotechnology & Pharmaceutical Companies

        12.4.2. Academic & Government Research Institutes

        12.4.3. Contract Research Organizations

    12.5. Market Value Forecast, by Country/Sub-region, 2023–2033

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Middle East & Africa Market Analysis and Forecast

    13.1. Introduction

    13.2. Market Value Forecast, by Product, 2023–2033

        13.2.1. Vector-based Cas

        13.2.2. DNA-free Cas

    13.3. Market Value Forecast, by Application, 2023–2033

        13.3.1. Genome Engineering

        13.3.2. Disease Models

        13.3.3. Functional Genomics

        13.3.4. Knockdown/activation

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2023–2033

        13.4.1. Biotechnology & Pharmaceutical Companies

        13.4.2. Academic & Government Research Institutes

        13.4.3. Contract Research Organizations

    13.5. Market Value Forecast, by Country/Sub-region, 2023–2033

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis, by Company (2018)

    14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)

        14.3.1. Synthego

            14.3.1.1. Company Overview

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Thermo Fisher Scientific, Inc.

            14.3.2.1. Company Overview

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. GenScript

            14.3.3.1. Company Overview

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Addgene

            14.3.4.1. Company Overview

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. Merck KGaA (Sigma-Aldrich)

            14.3.5.1. Company Overview

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Integrated DNA Technologies, Inc.

            14.3.6.1. Company Overview

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Transposagen Biopharmaceuticals, Inc.

            14.3.7.1. Company Overview

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. OriGene Technologies, Inc.

            14.3.8.1. Company Overview

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. New England Biolabs

            14.3.9.1. Company Overview

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. Dharmacon, a Horizon Discovery Group Co.

            14.3.10.1. Company Overview

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. SWOT Analysis

            14.3.10.5. Strategic Overview

        14.3.11. Cellecta, Inc.

            14.3.11.1. Company Overview

            14.3.11.2. Financial Overview

            14.3.11.3. Product Portfolio

            14.3.11.4. SWOT Analysis

            14.3.11.5. Strategic Overview

        14.3.12. Agilent Technologies

            14.3.12.1. Company Overview

            14.3.12.2. Financial Overview

            14.3.12.3. Product Portfolio

            14.3.12.4. SWOT Analysis

            14.3.12.5. Strategic Overview

        14.3.13. Applied StemCell, Inc.

            14.3.13.1. Company Overview

            14.3.13.2. Financial Overview

            14.3.13.3. Product Portfolio

            14.3.13.4. SWOT Analysis

            14.3.13.5. Strategic Overview

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Size (US$ Mn) Forecast, by Product, 2023–2033

Table 02: Global Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 03: Global Market Size (US$ Mn) Forecast, by End-user, 2023–2033

Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 05: North America Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 06: North America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 07: North America Market Size (US$ Mn) Forecast, by Application Type, 2023–2033

Table 08: North America Market Size (US$ Mn) Forecast, by End-user, 2023–2033

Table 09: Europe Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 10: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 11: Europe Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 12: Europe Market Size (US$ Mn) Forecast, by End-user, 2023–2033

Table 13: Asia Pacific Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 14: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 15: Asia Pacific Market Size (US$ Mn) Forecast, by Application Type, 2023–2033

Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2023–2033

Table 17: Latin America Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 18: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 19: Latin America Market Size (US$ Mn) Forecast, by Application Type, 2023–2033

Table 20: Latin America Market Size (US$ Mn) Forecast, by End-user, 2023–2033

Table 21: Middle East & Africa Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 22: Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2023–2033

Table 23: Middle East & Africa Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 24: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user, 2023–2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Size (US$ Mn) and Distribution, by Region, 2023 and 2033

Figure 02: Market Snapshot

Figure 03: Opportunity Map, 2022

Figure 04: Opportunity Map, 2022

Figure 05: Opportunity Map, 2022

Figure 06: Global Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033

Figure 07: Global Market Value Share, by Product, 2022

Figure 08: Global Market Value Share, by Application, 2022

Figure 09: Global Market Value Share, by End-user, 2022

Figure 10: Global Market Value Share, by Region, 2022

Figure 11: Global Market Value Share, by Product, 2023 and 2033

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vector-based Cas, 2023–2033

Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA-free Cas, 2023–2033

Figure 14: Global Market Attractiveness Analysis, by Product, 2023–2033

Figure 15: Global Market Value Share, by Application, 2023 and 2033

Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Genome Engineering, 2023–2033

Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Disease Models, 2023–2033

Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2023–2033

Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2023–2033

Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2023–2033

Figure 21: Global Market Attractiveness Analysis, by Application, 2023–2033

Figure 22: Global Market Value Share, by End-user, 2023 and 2033

Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2023–2033

Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Government Research Institutes, 2023–2033

Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2023–2033

Figure 26: Global Market Attractiveness Analysis, by End-user, 2023–2033

Figure 27: Global Market Value Share, by Region, 2023 and 2033

Figure 28: Global Market Attractiveness Analysis, by Region, 2023–2033

Figure 29: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033

Figure 30: North America Market Value Share, by Country, 2023 and 2033

Figure 31: North America Market Attractiveness, by Country, 2023–2033

Figure 32: North America Market Value Share, by Product Type, 2023 and 2033

Figure 33: North America Market Attractiveness, by Product Type, 2023–2033

Figure 34: North America Market Value Share, by Application Type, 2023 and 2033

Figure 35: North America Market Attractiveness, by Application Type, 2023–2033

Figure 36: North America Market Value Share, by End-user, 2023 and 2033

Figure 37: North America Market Attractiveness, by End-user, 2023–2033

Figure 38: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033

Figure 39: Europe Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 40: Europe Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 41: Europe Market Value Share, by Product Type, 2023 and 2033

Figure 42: Europe Market Attractiveness, by Product Type, 2023–2033

Figure 43: Europe Market Value Share, by Application, 2023 and 2033

Figure 44: Europe Market Attractiveness, by Application, 2023–2033

Figure 45: Europe Market Value Share, by End-user, 2023 and 2033

Figure 46: Europe Market Attractiveness, by End-user, 2023–2033

Figure 47: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033

Figure 48: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 49: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 50: Asia Pacific Market Value Share, by Product Type, 2023 and 2033

Figure 51: Asia Pacific Market Attractiveness, by Product Type, 2023–2033

Figure 52: Asia Pacific Market Value Share, by Application Type, 2023 and 2033

Figure 53: Asia Pacific Market Attractiveness, by Application Type, 2023–2033

Figure 54: Asia Pacific Market Value Share, by End-user, 2023 and 2033

Figure 55: Asia Pacific Market Attractiveness, by End-user, 2023–2033

Figure 56: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033

Figure 57: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 58: Latin America Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 59: Latin America Market Value Share, by Product Type, 2023 and 2033

Figure 60: Latin America Market Attractiveness, by Product Type, 2023–2033

Figure 61: Latin America Market Value Share, by Application Type, 2023 and 2033

Figure 62: Latin America Market Attractiveness, by Application Type, 2023–2033

Figure 63: Latin America Market Value Share, by End-user, 2023 and 2033

Figure 64: Latin America Market Attractiveness, by End-user, 2023–2033

Figure 65: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033

Figure 66: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 67: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 68: Middle East & Africa Market Value Share, by Product, 2023 and 2033

Figure 69: Middle East & Africa Market Attractiveness, by Product, 2023–2033

Figure 70: Middle East & Africa Market Value Share, by Application, 2023 and 2033

Figure 71: Middle East & Africa Market Attractiveness, by Application, 2023–2033

Figure 72: Middle East & Africa Market Value Share, by End-user, 2023 and 2033

Figure 73: Middle East & Africa Market Attractiveness, by End-user, 2023–2033

Figure 74: Thermo Fisher Scientific Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2022

Figure 75: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Region, 2022

Figure 76: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Business Segment, 2022

Figure 77: Thermo Fisher Scientific Inc. R&D Expense (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 78: GenScript Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 79: GenScript Breakdown of Net Sales, by Region, 2022

Figure 80: GenScript Breakdown of Net Sales, by Business Segment, 2022

Figure 81: GenScript R&D Expense (US$ Mn) and Selling and Distribution (US$ Mn), 2018–2022

Figure 82: Merck KGaA (Sigma Aldrich) Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2022

Figure 83: Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Region, 2022

Figure 84: Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Business Segment, 2022

Figure 85: Merck KGaA (Sigma Aldrich) Research & Development Market Share (%), by Business Segment, 2022

Figure 86: Agilent Technologies Breakdown of Net Sales, by Region, 2022

Figure 87: Agilent Technologies Breakdown of Net Sales (US$ Mn), by Segment, 2022

Figure 88: Agilent Technologies Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

CRISPR and Cas Genes Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services